Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma

Autor:	Beksac, Meral, Aydin, Yildiz, Goker, Hakan, Turgut, Mehmet, Besisik, Sevgi Kalayoglu, Cagirgan, Seckin, Tuglular, Tulin, Vural, Filiz, Yagci, Munci, Alacacioglu, Inci, Aytan, Pelin, Goksoy, Hasan Sami, Gulbas, Zafer, Gunes, Ahmet Kursad, Gurkan, Emel, Hacioglu, Sibel Kabukcu, Karti, Suleyman Sami, Kaynar, Leylagul, Ozdogu, Hakan, Paydas, Semra, Solmaz, Soner, Sonmez, Mehmet, Tekgunduz, Emre, Yildirim, Rahsan, Ilhan, Osman
Zdroj:	In Clinical Lymphoma, Myeloma and Leukemia August 2020 20(8):e474-e484
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect